CCMH
OREX

Cornerstone Capital Management Holdings’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,390
Closed -$64K – 1604
2016
Q1 		$64K Sell
11,390
-31,670
-74% -$411K ﹤0.01% 1373
2015
Q4 		$740K Buy
43,060
+22,960
+114% +$547K 0.01% 961
2015
Q3 		$424K Buy
20,100
+12,330
+159% +$423K ﹤0.01% 1056
2015
Q2 		$385K Buy
+7,770
New +$465K ﹤0.01% 1057
2014
Q4 		– Sell
-1,005
Closed -$43K – 1398
2014
Q3 		$43K Sell
1,005
-1,040
-51% -$55.8K ﹤0.01% 1222
2014
Q2 		$126K Buy
+2,045
New +$119K ﹤0.01% 1162

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cornerstone Capital Management Holdings's OREX Position: Q2 2016 in Review

Cornerstone Capital Management Holdings sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2016, closing a stake of 11,390 shares — an estimated $64K sold.

Cornerstone Capital Management Holdings first reported a position in OREX in Q2 2014 and held it in 6 quarters. The position peaked at $740K in Q4 2015. 73 funds tracked by Wall St. Rank hold OREX as of Q2 2016.

  • Cornerstone Capital Management Holdings reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 11,390 Orexigen Therapeutics, Inc. shares in Q2 2016, an estimated $64K.
  • Cornerstone Capital Management Holdings first reported a position in Orexigen Therapeutics, Inc. in Q2 2014 and held it in 6 quarters.
  • Cornerstone Capital Management Holdings's Orexigen Therapeutics, Inc. position peaked at $740K in Q4 2015.
  • 73 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2016, filed 12 Aug 2016.